Mark Lappe - Jan 3, 2023 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Executive Officer, Director
Signature
/s/ Kelly D. Deck, attorney-in-fact
Stock symbol
INBX
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 05:11 PM
Previous filing
Dec 20, 2022
Next filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +100K $0.00 100K Jan 3, 2023 Common Stock 100K $23.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments forthirty-six (36) months thereafter.